Key result
A 2012 review highlighted advances in cardiovascular disease prevention, including new European guidelines, biomarkers, imaging techniques, and lifestyle and pharmacological interventions.
A 2012 review summarizing European guidelines, biomarkers, imaging, and lifestyle/pharmacological advances in cardiovascular disease prevention.
Answers are grounded in this paper and cite their sources.
2012 prevention review provides historical benchmark; leaves open how subsequent evidence has updated guidelines and interventions.
Current data suggest that advances in cardiovascular (CV) treatment have resulted in significant reduction in CV mortality but also in prolongation of life with disability. Focus on CV prevention is likely to reverse this unfavourable trend. In this review we provide information on the new European guidelines on CV prevention and discuss biomarkers and vascular imaging techniques which can assist in refining CV risk prediction. Finally, we provide new information on lifestyle and pharmacological advances which are likely to result in significant CV risk reduction.
No takes yet. Share an insight, caveat, or question.
Charakida et al. (2013) conducted a review in Cardiovascular disease. Cardiovascular disease prevention strategies was evaluated. A 2012 review highlighted advances in cardiovascular disease prevention, including new European guidelines, biomarkers, imaging techniques, and lifestyle and pharmacological interventions.
Synapse has enriched 10 related papers. Consider them for comparative context: